dolastatin 10

N,N-dimethyl-L-valyl-N-[(3R,4S,5S)-3-methoxy-1-{(2S)-2-[(1R,2R)-1-methoxy-2-methyl-3-oxo-3-{[(1S)-2-phenyl-1-(1,3-thiazol-2-yl)ethyl]amino}propyl]pyrrolidin-1-yl}-5-methyl-1-oxoheptan-4-yl]-N-methyl-L-valinamide

OFDNQWIFNXBECV-VFSYNPLYSA-N CHEBI:67357 0 Reactome links 2 studies

Metabolite details

Identifier: OFDNQWIFNXBECV-VFSYNPLYSA-N
InChI Key: OFDNQWIFNXBECV-VFSYNPLYSA-N
IUPAC name: N,N-dimethyl-L-valyl-N-[(3R,4S,5S)-3-methoxy-1-{(2S)-2-[(1R,2R)-1-methoxy-2-methyl-3-oxo-3-{[(1S)-2-phenyl-1-(1,3-thiazol-2-yl)ethyl]amino}propyl]pyrrolidin-1-yl}-5-methyl-1-oxoheptan-4-yl]-N-methyl-L-valinamide
Preferred name: dolastatin 10
INN name: —
Synonym: DLS-10
ChEBI: CHEBI:67357

Reactome pathways

No Reactome pathways listed for this metabolite.

Observed in studies

Hfq Regulates Efflux Pump Expression and Purine Metabolic Pathway to Increase the Trimethoprim Resistance in Aeromonas veronii
Transcriptomics and metabolomics of engineered Synechococcus elongatus during photomixotrophic growth

Observed in differential profiles

Wild_type_vs_hfq
Wild_Type_vs_YQ2-gal